Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Uveal Melanoma × Melatonin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Parasomnias 2 Weight Loss 1 Uveal Melanoma 1 Tuberous Sclerosis 1 Squamous Cell Carcinoma of Head and Neck 1 Smith-Magenis Syndrome 1 Sleep Wake Disorders 1 Neoplasms 1 Lung Neoplasms 1 Gastrointestinal Neoplasms 1 Cachexia 1 Breast Cancer - Female 1 Barrett Esophagus 1 Autism Spectrum Disorder 1 Anorexia 1 Angelman Syndrome 1

Interventions

Melphalan 3 tebentafusp 1 sargramostim 1 fotemustine 1 aflibercept 1 Ranibizumab 1 Nivolumab 1 Neoadjuvant Therapy 1 Melatonin 1 MART-1 Antigen 1 Ipilimumab 1 Eye Enucleation 1 Colony-Stimulating Factors 1 Chemotherapy, Cancer, Regional Perfusion 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05502900 2025-05-15

AMUM

St. Erik Eye Hospital

Phase 3 Recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡